Table 3 Differences in SWE values and histologic biomarkers according to GLUT1 expression
| Â | GLUT1 | *p value | |
|---|---|---|---|
≤median (n = 41) | >median (n = 41) | ||
Eaverage | 85. 4 ± 29.3 kPa | 125.5 ± 14.8 kPa | < 0.001 |
Eratio | 11.7 ± 5.7 | 17.9 ± 9.6 | < 0.001 |
Lymph node | Â | Â | 0.373 |
 negative | 21 (45.7) | 25 (54.3) |  |
 positive | 20 (55.6) | 16 (44.4) |  |
ER | Â | Â | 0.001 |
 negative | 5 (21.7) | 18 (78.3) |  |
 positive | 36 (61.0) | 23 (39.0) |  |
PR | Â | Â | 0.004 |
 negative | 7 (26.9) | 19 (73.1) |  |
 positive | 34 (60.7) | 22 (39.3) |  |
HER2 | Â | Â | 0.026 |
 negative | 37 (56.1) | 29 (43.9) |  |
 positive | 4 (25.0) | 12 (75.0) |  |
Ki67 | Â | Â | 0.001 |
 negative | 28 (68.3) | 13 (31.7) |  |
 positive | 13 (31.7) | 28 (68.3) |  |
Tumor grade | Â | Â | 0.005 |
 1 or 2 | 33 (61.1) | 21 (38.9) |  |
 3 | 8 (28.6) | 20 (71.4) |  |
Molecular subtype | Â | Â | 0.001 |
 luminal A cancer | 21 (80.8) | 5 (19.2) |  |
 luminal B cancer | 15 (42.9) | 20 (57.1) |  |
 HER2-overexpressing cancer | 2 (25.0) | 6 (75.0) |  |
 triple-negative cancer | 3 (23.1) | 10 (76.9) |  |